As of 2025-03-22, the Relative Valuation of Poseida Therapeutics, Inc. (PSTX) is (6.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.50 USD, the upside of Poseida Therapeutics, Inc. based on Relative Valuation is -168.2%.
The range of the Relative Valuation is (3.18) - (9.48) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 16.3x | 10.6x |
| Forward P/E multiples | 5.1x - 15.2x | 10.1x |
| Fair Price | (3.18) - (9.48) | (6.48) |
| Upside | -133.5% - -199.7% | -168.2% |
| Date | P/E |
| 2025-01-08 | -15.24 |
| 2025-01-07 | -15.24 |
| 2025-01-06 | -15.34 |
| 2025-01-03 | -15.27 |
| 2025-01-02 | -15.08 |
| 2024-12-31 | -15.40 |
| 2024-12-30 | -15.21 |
| 2024-12-27 | -15.11 |
| 2024-12-26 | -15.26 |
| 2024-12-24 | -15.22 |
| 2024-12-23 | -15.21 |
| 2024-12-20 | -15.16 |
| 2024-12-19 | -15.10 |
| 2024-12-18 | -15.14 |
| 2024-12-17 | -15.24 |
| 2024-12-16 | -15.26 |
| 2024-12-13 | -15.26 |
| 2024-12-12 | -15.24 |
| 2024-12-11 | -15.26 |
| 2024-12-10 | -15.16 |
| 2024-12-09 | -15.14 |
| 2024-12-06 | -15.02 |
| 2024-12-05 | -14.97 |